NFE2L2 and breast carcinoma: For further analysis using a mouse model of induced breast cancer, the reduced expression of CAV-1 triggers the activation of NRF2 and the subsequent upregulation of SOD-2, stimulating an AMPK-dependent glycolytic switch permissible to gaining an extremely highly aggressive state [182].